 | • レポートコード：MRC2Q12-19387 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、組換えタンパク質発現システムの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に組換えタンパク質発現システムのグローバル市場のxxx％を占める「哺乳類細胞発現系」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬会社」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 組換えタンパク質発現システムの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの組換えタンパク質発現システム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 組換えタンパク質発現システムのグローバル主要プレイヤーには、Thermo Fisher、Merck、GenScript、Agilent、Takara Bio、Bio-Rad Laboratories、Qiagen N.V、Charles River、Sartorius、Corning、FUJIFILM Irvine Scientific、Lonza Group、Bioneer Corporation、Promega、Oxford Expression Technologies、ProteoGenix、Abeomics、New England Biolabs、Promab Biotechnologies、Sino Biological、Jena Bioscience、Lifesensors、Leading biology、Peak Proteinsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 組換えタンパク質発現システム市場は、種類と用途によって区分されます。世界の組換えタンパク質発現システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 哺乳類細胞発現系、原核細胞発現系、昆虫細胞発現系、酵母発現系、無細胞発現系、藻類系発現系 【用途別セグメント】 製薬会社、研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 組換えタンパク質発現システム製品概要 - 種類別市場（哺乳類細胞発現系、原核細胞発現系、昆虫細胞発現系、酵母発現系、無細胞発現系、藻類系発現系） - 用途別市場（製薬会社、研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の組換えタンパク質発現システム販売量予測2017-2028 - 世界の組換えタンパク質発現システム売上予測2017-2028 - 組換えタンパク質発現システムの地域別販売量 - 組換えタンパク質発現システムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別組換えタンパク質発現システム販売量 - 主要メーカー別組換えタンパク質発現システム売上 - 主要メーカー別組換えタンパク質発現システム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（哺乳類細胞発現系、原核細胞発現系、昆虫細胞発現系、酵母発現系、無細胞発現系、藻類系発現系） - 組換えタンパク質発現システムの種類別販売量 - 組換えタンパク質発現システムの種類別売上 - 組換えタンパク質発現システムの種類別価格 ・用途別市場規模（製薬会社、研究機関、その他） - 組換えタンパク質発現システムの用途別販売量 - 組換えタンパク質発現システムの用途別売上 - 組換えタンパク質発現システムの用途別価格 ・北米市場 - 北米の組換えタンパク質発現システム市場規模（種類別、用途別） - 主要国別の組換えタンパク質発現システム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの組換えタンパク質発現システム市場規模（種類別、用途別） - 主要国別の組換えタンパク質発現システム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の組換えタンパク質発現システム市場規模（種類別、用途別） - 主要国別の組換えタンパク質発現システム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の組換えタンパク質発現システム市場規模（種類別、用途別） - 主要国別の組換えタンパク質発現システム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの組換えタンパク質発現システム市場規模（種類別、用途別） - 主要国別の組換えタンパク質発現システム市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher、Merck、GenScript、Agilent、Takara Bio、Bio-Rad Laboratories、Qiagen N.V、Charles River、Sartorius、Corning、FUJIFILM Irvine Scientific、Lonza Group、Bioneer Corporation、Promega、Oxford Expression Technologies、ProteoGenix、Abeomics、New England Biolabs、Promab Biotechnologies、Sino Biological、Jena Bioscience、Lifesensors、Leading biology、Peak Proteins ・産業チェーン及び販売チャネル分析 - 組換えタンパク質発現システムの産業チェーン分析 - 組換えタンパク質発現システムの原材料 - 組換えタンパク質発現システムの生産プロセス - 組換えタンパク質発現システムの販売及びマーケティング - 組換えタンパク質発現システムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 組換えタンパク質発現システムの産業動向 - 組換えタンパク質発現システムのマーケットドライバー - 組換えタンパク質発現システムの課題 - 組換えタンパク質発現システムの阻害要因 ・主な調査結果 |
Proteins produced from such DNA templates are called recombinant proteins. Traditional strategies for recombinant protein expression involve transfecting cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Recombinant Protein Expression System estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Recombinant Protein Expression System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Recombinant Protein Expression System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Recombinant Protein Expression System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Recombinant Protein Expression System include Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Recombinant Protein Expression System companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Recombinant Protein Expression System market. Further, it explains the major drivers and regional dynamics of the global Recombinant Protein Expression System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Recombinant Protein Expression System Segment by Type
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Recombinant Protein Expression System Segment by Application
Pharmaceutical Companies
Research Institutes
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Recombinant Protein Expression System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Recombinant Protein Expression System market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Recombinant Protein Expression System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Protein Expression System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Protein Expression System revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Recombinant Protein Expression System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Recombinant Protein Expression System revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Recombinant Protein Expression System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Expression System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Expression System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Expression System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mammalian Cell Expression System
1.2.3 Prokaryotic Expression System
1.2.4 Insect Cell Expression System
1.2.5 Yeast Expression System
1.2.6 Cell-free Expression System
1.2.7 Algal-based Expression System
1.3 Market by Application
1.3.1 Global Recombinant Protein Expression System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Protein Expression System Market Perspective (2017-2028)
2.2 Recombinant Protein Expression System Growth Trends by Region
2.2.1 Recombinant Protein Expression System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Recombinant Protein Expression System Historic Market Size by Region (2017-2022)
2.2.3 Recombinant Protein Expression System Forecasted Market Size by Region (2023-2028)
2.3 Recombinant Protein Expression System Market Dynamics
2.3.1 Recombinant Protein Expression System Industry Trends
2.3.2 Recombinant Protein Expression System Market Drivers
2.3.3 Recombinant Protein Expression System Market Challenges
2.3.4 Recombinant Protein Expression System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Expression System Players by Revenue
3.1.1 Global Top Recombinant Protein Expression System Players by Revenue (2017-2022)
3.1.2 Global Recombinant Protein Expression System Revenue Market Share by Players (2017-2022)
3.2 Global Recombinant Protein Expression System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Expression System Revenue
3.4 Global Recombinant Protein Expression System Market Concentration Ratio
3.4.1 Global Recombinant Protein Expression System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Expression System Revenue in 2021
3.5 Recombinant Protein Expression System Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Expression System Product Solution and Service
3.7 Date of Enter into Recombinant Protein Expression System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Protein Expression System Breakdown Data by Type
4.1 Global Recombinant Protein Expression System Historic Market Size by Type (2017-2022)
4.2 Global Recombinant Protein Expression System Forecasted Market Size by Type (2023-2028)
5 Recombinant Protein Expression System Breakdown Data by Application
5.1 Global Recombinant Protein Expression System Historic Market Size by Application (2017-2022)
5.2 Global Recombinant Protein Expression System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Recombinant Protein Expression System Market Size (2017-2028)
6.2 North America Recombinant Protein Expression System Market Size by Type
6.2.1 North America Recombinant Protein Expression System Market Size by Type (2017-2022)
6.2.2 North America Recombinant Protein Expression System Market Size by Type (2023-2028)
6.2.3 North America Recombinant Protein Expression System Market Share by Type (2017-2028)
6.3 North America Recombinant Protein Expression System Market Size by Application
6.3.1 North America Recombinant Protein Expression System Market Size by Application (2017-2022)
6.3.2 North America Recombinant Protein Expression System Market Size by Application (2023-2028)
6.3.3 North America Recombinant Protein Expression System Market Share by Application (2017-2028)
6.4 North America Recombinant Protein Expression System Market Size by Country
6.4.1 North America Recombinant Protein Expression System Market Size by Country (2017-2022)
6.4.2 North America Recombinant Protein Expression System Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Protein Expression System Market Size (2017-2028)
7.2 Europe Recombinant Protein Expression System Market Size by Type
7.2.1 Europe Recombinant Protein Expression System Market Size by Type (2017-2022)
7.2.2 Europe Recombinant Protein Expression System Market Size by Type (2023-2028)
7.2.3 Europe Recombinant Protein Expression System Market Share by Type (2017-2028)
7.3 Europe Recombinant Protein Expression System Market Size by Application
7.3.1 Europe Recombinant Protein Expression System Market Size by Application (2017-2022)
7.3.2 Europe Recombinant Protein Expression System Market Size by Application (2023-2028)
7.3.3 Europe Recombinant Protein Expression System Market Share by Application (2017-2028)
7.4 Europe Recombinant Protein Expression System Market Size by Country
7.4.1 Europe Recombinant Protein Expression System Market Size by Country (2017-2022)
7.4.2 Europe Recombinant Protein Expression System Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Expression System Market Size (2017-2028)
8.2 Asia-Pacific Recombinant Protein Expression System Market Size by Type
8.2.1 Asia-Pacific Recombinant Protein Expression System Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Recombinant Protein Expression System Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Recombinant Protein Expression System Market Share by Type (2017-2028)
8.3 Asia-Pacific Recombinant Protein Expression System Market Size by Application
8.3.1 Asia-Pacific Recombinant Protein Expression System Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Recombinant Protein Expression System Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Recombinant Protein Expression System Market Share by Application (2017-2028)
8.4 Asia-Pacific Recombinant Protein Expression System Market Size by Region
8.4.1 Asia-Pacific Recombinant Protein Expression System Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Recombinant Protein Expression System Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Protein Expression System Market Size (2017-2028)
9.2 Latin America Recombinant Protein Expression System Market Size by Type
9.2.1 Latin America Recombinant Protein Expression System Market Size by Type (2017-2022)
9.2.2 Latin America Recombinant Protein Expression System Market Size by Type (2023-2028)
9.2.3 Latin America Recombinant Protein Expression System Market Share by Type (2017-2028)
9.3 Latin America Recombinant Protein Expression System Market Size by Application
9.3.1 Latin America Recombinant Protein Expression System Market Size by Application (2017-2022)
9.3.2 Latin America Recombinant Protein Expression System Market Size by Application (2023-2028)
9.3.3 Latin America Recombinant Protein Expression System Market Share by Application (2017-2028)
9.4 Latin America Recombinant Protein Expression System Market Size by Country
9.4.1 Latin America Recombinant Protein Expression System Market Size by Country (2017-2022)
9.4.2 Latin America Recombinant Protein Expression System Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Expression System Market Size (2017-2028)
10.2 Middle East & Africa Recombinant Protein Expression System Market Size by Type
10.2.1 Middle East & Africa Recombinant Protein Expression System Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Recombinant Protein Expression System Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Recombinant Protein Expression System Market Share by Type (2017-2028)
10.3 Middle East & Africa Recombinant Protein Expression System Market Size by Application
10.3.1 Middle East & Africa Recombinant Protein Expression System Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Recombinant Protein Expression System Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Recombinant Protein Expression System Market Share by Application (2017-2028)
10.4 Middle East & Africa Recombinant Protein Expression System Market Size by Country
10.4.1 Middle East & Africa Recombinant Protein Expression System Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Recombinant Protein Expression System Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Recombinant Protein Expression System Introduction
11.1.4 Thermo Fisher Revenue in Recombinant Protein Expression System Business (2017-2022)
11.1.5 Thermo Fisher Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Recombinant Protein Expression System Introduction
11.2.4 Merck Revenue in Recombinant Protein Expression System Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Recombinant Protein Expression System Introduction
11.3.4 GenScript Revenue in Recombinant Protein Expression System Business (2017-2022)
11.3.5 GenScript Recent Developments
11.4 Agilent
11.4.1 Agilent Company Details
11.4.2 Agilent Business Overview
11.4.3 Agilent Recombinant Protein Expression System Introduction
11.4.4 Agilent Revenue in Recombinant Protein Expression System Business (2017-2022)
11.4.5 Agilent Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Recombinant Protein Expression System Introduction
11.5.4 Takara Bio Revenue in Recombinant Protein Expression System Business (2017-2022)
11.5.5 Takara Bio Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Recombinant Protein Expression System Introduction
11.6.4 Bio-Rad Laboratories Revenue in Recombinant Protein Expression System Business (2017-2022)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Qiagen N.V
11.7.1 Qiagen N.V Company Details
11.7.2 Qiagen N.V Business Overview
11.7.3 Qiagen N.V Recombinant Protein Expression System Introduction
11.7.4 Qiagen N.V Revenue in Recombinant Protein Expression System Business (2017-2022)
11.7.5 Qiagen N.V Recent Developments
11.8 Charles River
11.8.1 Charles River Company Details
11.8.2 Charles River Business Overview
11.8.3 Charles River Recombinant Protein Expression System Introduction
11.8.4 Charles River Revenue in Recombinant Protein Expression System Business (2017-2022)
11.8.5 Charles River Recent Developments
11.9 Sartorius
11.9.1 Sartorius Company Details
11.9.2 Sartorius Business Overview
11.9.3 Sartorius Recombinant Protein Expression System Introduction
11.9.4 Sartorius Revenue in Recombinant Protein Expression System Business (2017-2022)
11.9.5 Sartorius Recent Developments
11.10 Corning
11.10.1 Corning Company Details
11.10.2 Corning Business Overview
11.10.3 Corning Recombinant Protein Expression System Introduction
11.10.4 Corning Revenue in Recombinant Protein Expression System Business (2017-2022)
11.10.5 Corning Recent Developments
11.11 FUJIFILM Irvine Scientific
11.11.1 FUJIFILM Irvine Scientific Company Details
11.11.2 FUJIFILM Irvine Scientific Business Overview
11.11.3 FUJIFILM Irvine Scientific Recombinant Protein Expression System Introduction
11.11.4 FUJIFILM Irvine Scientific Revenue in Recombinant Protein Expression System Business (2017-2022)
11.11.5 FUJIFILM Irvine Scientific Recent Developments
11.12 Lonza Group
11.12.1 Lonza Group Company Details
11.12.2 Lonza Group Business Overview
11.12.3 Lonza Group Recombinant Protein Expression System Introduction
11.12.4 Lonza Group Revenue in Recombinant Protein Expression System Business (2017-2022)
11.12.5 Lonza Group Recent Developments
11.13 Bioneer Corporation
11.13.1 Bioneer Corporation Company Details
11.13.2 Bioneer Corporation Business Overview
11.13.3 Bioneer Corporation Recombinant Protein Expression System Introduction
11.13.4 Bioneer Corporation Revenue in Recombinant Protein Expression System Business (2017-2022)
11.13.5 Bioneer Corporation Recent Developments
11.14 Promega
11.14.1 Promega Company Details
11.14.2 Promega Business Overview
11.14.3 Promega Recombinant Protein Expression System Introduction
11.14.4 Promega Revenue in Recombinant Protein Expression System Business (2017-2022)
11.14.5 Promega Recent Developments
11.15 Oxford Expression Technologies
11.15.1 Oxford Expression Technologies Company Details
11.15.2 Oxford Expression Technologies Business Overview
11.15.3 Oxford Expression Technologies Recombinant Protein Expression System Introduction
11.15.4 Oxford Expression Technologies Revenue in Recombinant Protein Expression System Business (2017-2022)
11.15.5 Oxford Expression Technologies Recent Developments
11.16 ProteoGenix
11.16.1 ProteoGenix Company Details
11.16.2 ProteoGenix Business Overview
11.16.3 ProteoGenix Recombinant Protein Expression System Introduction
11.16.4 ProteoGenix Revenue in Recombinant Protein Expression System Business (2017-2022)
11.16.5 ProteoGenix Recent Developments
11.17 Abeomics
11.17.1 Abeomics Company Details
11.17.2 Abeomics Business Overview
11.17.3 Abeomics Recombinant Protein Expression System Introduction
11.17.4 Abeomics Revenue in Recombinant Protein Expression System Business (2017-2022)
11.17.5 Abeomics Recent Developments
11.18 New England Biolabs
11.18.1 New England Biolabs Company Details
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Recombinant Protein Expression System Introduction
11.18.4 New England Biolabs Revenue in Recombinant Protein Expression System Business (2017-2022)
11.18.5 New England Biolabs Recent Developments
11.19 Promab Biotechnologies
11.19.1 Promab Biotechnologies Company Details
11.19.2 Promab Biotechnologies Business Overview
11.19.3 Promab Biotechnologies Recombinant Protein Expression System Introduction
11.19.4 Promab Biotechnologies Revenue in Recombinant Protein Expression System Business (2017-2022)
11.19.5 Promab Biotechnologies Recent Developments
11.20 Sino Biological
11.20.1 Sino Biological Company Details
11.20.2 Sino Biological Business Overview
11.20.3 Sino Biological Recombinant Protein Expression System Introduction
11.20.4 Sino Biological Revenue in Recombinant Protein Expression System Business (2017-2022)
11.20.5 Sino Biological Recent Developments
11.21 Jena Bioscience
11.21.1 Jena Bioscience Company Details
11.21.2 Jena Bioscience Business Overview
11.21.3 Jena Bioscience Recombinant Protein Expression System Introduction
11.21.4 Jena Bioscience Revenue in Recombinant Protein Expression System Business (2017-2022)
11.21.5 Jena Bioscience Recent Developments
11.22 Lifesensors
11.22.1 Lifesensors Company Details
11.22.2 Lifesensors Business Overview
11.22.3 Lifesensors Recombinant Protein Expression System Introduction
11.22.4 Lifesensors Revenue in Recombinant Protein Expression System Business (2017-2022)
11.22.5 Lifesensors Recent Developments
11.23 Leading biology
11.23.1 Leading biology Company Details
11.23.2 Leading biology Business Overview
11.23.3 Leading biology Recombinant Protein Expression System Introduction
11.23.4 Leading biology Revenue in Recombinant Protein Expression System Business (2017-2022)
11.23.5 Leading biology Recent Developments
11.24 Peak Proteins
11.24.1 Peak Proteins Company Details
11.24.2 Peak Proteins Business Overview
11.24.3 Peak Proteins Recombinant Protein Expression System Introduction
11.24.4 Peak Proteins Revenue in Recombinant Protein Expression System Business (2017-2022)
11.24.5 Peak Proteins Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Recombinant Protein Expression System Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Mammalian Cell Expression System
Table 3. Key Players of Prokaryotic Expression System
Table 4. Key Players of Insect Cell Expression System
Table 5. Key Players of Yeast Expression System
Table 6. Key Players of Cell-free Expression System
Table 7. Key Players of Algal-based Expression System
Table 8. Global Recombinant Protein Expression System Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Recombinant Protein Expression System Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Recombinant Protein Expression System Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Recombinant Protein Expression System Market Share by Region (2017-2022)
Table 12. Global Recombinant Protein Expression System Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Recombinant Protein Expression System Market Share by Region (2023-2028)
Table 14. Recombinant Protein Expression System Market Trends
Table 15. Recombinant Protein Expression System Market Drivers
Table 16. Recombinant Protein Expression System Market Challenges
Table 17. Recombinant Protein Expression System Market Restraints
Table 18. Global Recombinant Protein Expression System Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Recombinant Protein Expression System Revenue Share by Players (2017-2022)
Table 20. Global Top Recombinant Protein Expression System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Expression System as of 2021)
Table 21. Ranking of Global Top Recombinant Protein Expression System Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Recombinant Protein Expression System Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Recombinant Protein Expression System Product Solution and Service
Table 25. Date of Enter into Recombinant Protein Expression System Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Protein Expression System Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Recombinant Protein Expression System Revenue Market Share by Type (2017-2022)
Table 29. Global Recombinant Protein Expression System Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Recombinant Protein Expression System Revenue Market Share by Type (2023-2028)
Table 31. Global Recombinant Protein Expression System Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Recombinant Protein Expression System Revenue Share by Application (2017-2022)
Table 33. Global Recombinant Protein Expression System Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Recombinant Protein Expression System Revenue Share by Application (2023-2028)
Table 35. North America Recombinant Protein Expression System Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Recombinant Protein Expression System Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Recombinant Protein Expression System Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Recombinant Protein Expression System Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Recombinant Protein Expression System Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Recombinant Protein Expression System Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Recombinant Protein Expression System Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Recombinant Protein Expression System Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Recombinant Protein Expression System Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Recombinant Protein Expression System Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Recombinant Protein Expression System Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Recombinant Protein Expression System Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Recombinant Protein Expression System Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Recombinant Protein Expression System Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Recombinant Protein Expression System Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Recombinant Protein Expression System Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Recombinant Protein Expression System Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Recombinant Protein Expression System Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Recombinant Protein Expression System Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Recombinant Protein Expression System Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Recombinant Protein Expression System Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Recombinant Protein Expression System Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Recombinant Protein Expression System Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Recombinant Protein Expression System Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Recombinant Protein Expression System Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Recombinant Protein Expression System Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Recombinant Protein Expression System Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Recombinant Protein Expression System Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Recombinant Protein Expression System Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Recombinant Protein Expression System Market Size by Country (2023-2028) & (US$ Million)
Table 65. Thermo Fisher Company Details
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher Recombinant Protein Expression System Product
Table 68. Thermo Fisher Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Recent Developments
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Recombinant Protein Expression System Product
Table 73. Merck Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 74. Merck Recent Developments
Table 75. GenScript Company Details
Table 76. GenScript Business Overview
Table 77. GenScript Recombinant Protein Expression System Product
Table 78. GenScript Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 79. GenScript Recent Developments
Table 80. Agilent Company Details
Table 81. Agilent Business Overview
Table 82. Agilent Recombinant Protein Expression System Product
Table 83. Agilent Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 84. Agilent Recent Developments
Table 85. Takara Bio Company Details
Table 86. Takara Bio Business Overview
Table 87. Takara Bio Recombinant Protein Expression System Product
Table 88. Takara Bio Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 89. Takara Bio Recent Developments
Table 90. Bio-Rad Laboratories Company Details
Table 91. Bio-Rad Laboratories Business Overview
Table 92. Bio-Rad Laboratories Recombinant Protein Expression System Product
Table 93. Bio-Rad Laboratories Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 94. Bio-Rad Laboratories Recent Developments
Table 95. Qiagen N.V Company Details
Table 96. Qiagen N.V Business Overview
Table 97. Qiagen N.V Recombinant Protein Expression System Product
Table 98. Qiagen N.V Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 99. Qiagen N.V Recent Developments
Table 100. Charles River Company Details
Table 101. Charles River Business Overview
Table 102. Charles River Recombinant Protein Expression System Product
Table 103. Charles River Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 104. Charles River Recent Developments
Table 105. Sartorius Company Details
Table 106. Sartorius Business Overview
Table 107. Sartorius Recombinant Protein Expression System Product
Table 108. Sartorius Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 109. Sartorius Recent Developments
Table 110. Corning Company Details
Table 111. Corning Business Overview
Table 112. Corning Recombinant Protein Expression System Product
Table 113. Corning Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 114. Corning Recent Developments
Table 115. FUJIFILM Irvine Scientific Company Details
Table 116. FUJIFILM Irvine Scientific Business Overview
Table 117. FUJIFILM Irvine Scientific Recombinant Protein Expression System Product
Table 118. FUJIFILM Irvine Scientific Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 119. FUJIFILM Irvine Scientific Recent Developments
Table 120. Lonza Group Company Details
Table 121. Lonza Group Business Overview
Table 122. Lonza Group Recombinant Protein Expression System Product
Table 123. Lonza Group Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 124. Lonza Group Recent Developments
Table 125. Bioneer Corporation Company Details
Table 126. Bioneer Corporation Business Overview
Table 127. Bioneer Corporation Recombinant Protein Expression System Product
Table 128. Bioneer Corporation Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 129. Bioneer Corporation Recent Developments
Table 130. Promega Company Details
Table 131. Promega Business Overview
Table 132. Promega Recombinant Protein Expression System Product
Table 133. Promega Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 134. Promega Recent Developments
Table 135. Oxford Expression Technologies Company Details
Table 136. Oxford Expression Technologies Business Overview
Table 137. Oxford Expression Technologies Recombinant Protein Expression System Product
Table 138. Oxford Expression Technologies Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 139. Oxford Expression Technologies Recent Developments
Table 140. ProteoGenix Company Details
Table 141. ProteoGenix Business Overview
Table 142. ProteoGenix Recombinant Protein Expression System Product
Table 143. ProteoGenix Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 144. ProteoGenix Recent Developments
Table 145. Abeomics Company Details
Table 146. Abeomics Business Overview
Table 147. Abeomics Recombinant Protein Expression System Product
Table 148. Abeomics Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 149. Abeomics Recent Developments
Table 150. New England Biolabs Company Details
Table 151. New England Biolabs Business Overview
Table 152. New England Biolabs Recombinant Protein Expression System Product
Table 153. New England Biolabs Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 154. New England Biolabs Recent Developments
Table 155. Promab Biotechnologies Company Details
Table 156. Promab Biotechnologies Business Overview
Table 157. Promab Biotechnologies Recombinant Protein Expression System Product
Table 158. Promab Biotechnologies Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 159. Promab Biotechnologies Recent Developments
Table 160. Sino Biological Company Details
Table 161. Sino Biological Business Overview
Table 162. Sino Biological Recombinant Protein Expression System Product
Table 163. Sino Biological Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 164. Sino Biological Recent Developments
Table 165. Jena Bioscience Company Details
Table 166. Jena Bioscience Business Overview
Table 167. Jena Bioscience Recombinant Protein Expression System Product
Table 168. Jena Bioscience Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 169. Jena Bioscience Recent Developments
Table 170. Lifesensors Company Details
Table 171. Lifesensors Business Overview
Table 172. Lifesensors Recombinant Protein Expression System Product
Table 173. Lifesensors Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 174. Lifesensors Recent Developments
Table 175. Leading biology Company Details
Table 176. Leading biology Business Overview
Table 177. Leading biology Recombinant Protein Expression System Product
Table 178. Leading biology Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 179. Leading biology Recent Developments
Table 180. Peak Proteins Company Details
Table 181. Peak Proteins Business Overview
Table 182. Peak Proteins Recombinant Protein Expression System Product
Table 183. Peak Proteins Revenue in Recombinant Protein Expression System Business (2017-2022) & (US$ Million)
Table 184. Peak Proteins Recent Developments
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Protein Expression System Market Share by Type: 2021 VS 2028
Figure 2. Mammalian Cell Expression System Features
Figure 3. Prokaryotic Expression System Features
Figure 4. Insect Cell Expression System Features
Figure 5. Yeast Expression System Features
Figure 6. Cell-free Expression System Features
Figure 7. Algal-based Expression System Features
Figure 8. Global Recombinant Protein Expression System Market Share by Application: 2021 VS 2028
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Recombinant Protein Expression System Report Years Considered
Figure 13. Global Recombinant Protein Expression System Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Recombinant Protein Expression System Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Recombinant Protein Expression System Market Share by Region: 2021 VS 2028
Figure 16. Global Recombinant Protein Expression System Market Share by Players in 2021
Figure 17. Global Top Recombinant Protein Expression System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Expression System as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Protein Expression System Revenue in 2021
Figure 19. North America Recombinant Protein Expression System Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Recombinant Protein Expression System Market Size Market Share by Type (2017-2028)
Figure 21. North America Recombinant Protein Expression System Market Size Market Share by Application (2017-2028)
Figure 22. North America Recombinant Protein Expression System Market Size Share by Country (2017-2028)
Figure 23. United States Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Recombinant Protein Expression System Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Recombinant Protein Expression System Market Size Market Share by Type (2017-2028)
Figure 27. Europe Recombinant Protein Expression System Market Size Market Share by Application (2017-2028)
Figure 28. Europe Recombinant Protein Expression System Market Size Share by Country (2017-2028)
Figure 29. Germany Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Protein Expression System Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Recombinant Protein Expression System Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Recombinant Protein Expression System Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Recombinant Protein Expression System Market Size Share by Region (2017-2028)
Figure 39. China Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Recombinant Protein Expression System Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Recombinant Protein Expression System Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Recombinant Protein Expression System Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Recombinant Protein Expression System Market Size Share by Country (2017-2028)
Figure 49. Mexico Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Recombinant Protein Expression System Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Recombinant Protein Expression System Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Recombinant Protein Expression System Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Recombinant Protein Expression System Market Size Share by Country (2017-2028)
Figure 55. Turkey Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Recombinant Protein Expression System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Thermo Fisher Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 60. GenScript Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 61. Agilent Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 62. Takara Bio Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 64. Qiagen N.V Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 65. Charles River Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 66. Sartorius Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 67. Corning Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 68. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 69. Lonza Group Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 70. Bioneer Corporation Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 71. Promega Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 72. Oxford Expression Technologies Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 73. ProteoGenix Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 74. Abeomics Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 75. New England Biolabs Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 76. Promab Biotechnologies Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 77. Sino Biological Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 78. Jena Bioscience Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 79. Lifesensors Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 80. Leading biology Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 81. Peak Proteins Revenue Growth Rate in Recombinant Protein Expression System Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed